Education
About Us
Working with TipRanks
Follow Us
Orphazyme A/S (DE:1TB0)
:1TB0
| Dec 21 | Dec 20 | Dec 19 | Dec 18 | Dec 17 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | |||||
| Gross Profit | $ 36.19M | $ -247.25M | - | - | - |
| Operating Income | $ -633.30M | $ -637.61M | $ -335.95M | $ -231.65M | $ -117.59M |
| EBITDA | $ -602.76M | $ -629.36M | $ -334.39M | $ -230.91M | $ -130.27M |
| Net Income | $ -626.54M | $ -632.64M | $ -337.50M | $ -229.60M | $ -126.20M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ ― | $ ― | $ ― | $ ― | $ ― |
| Total Assets | $ 173.23M | $ 822.49M | $ 180.75M | $ 441.35M | $ 662.82M |
| Total Debt | $ 39.97M | $ 70.71M | $ 77.11M | $ 0.00 | $ 0.00 |
| Net Debt | $ -62.29M | $ -656.22M | $ -46.48M | $ -394.71M | $ -631.74M |
| Total Liabilities | $ 201.74M | $ 243.16M | $ 127.78M | $ 53.10M | $ 47.12M |
| Stockholders' Equity | $ ― | $ ― | $ ― | $ ― | $ ― |
| Cash Flow | |||||
| Free Cash Flow | $ -602.52M | $ -544.18M | $ -330.10M | $ -237.11M | $ -96.92M |
| Operating Cash Flow | $ -602.57M | $ -539.08M | $ -326.82M | $ -234.76M | $ -95.43M |
| Investing Cash Flow | |||||
| Financing Cash Flow |
Orphazyme Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.